News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
489,794 Results
Type
Article (8019)
Company Profile (150)
Press Release (481625)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166738)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238191)
Policy (17898)
Tag
2025 Best Places to Work (5)
2026 Best Places to Work (12)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (502)
Accelerated approval (31)
ADA (18)
Adcomms (1)
Allergies (103)
Alliances (33156)
ALS (122)
Alzheimer's disease (1020)
Antibody-drug conjugate (ADC) (338)
Approvals (10496)
Artificial intelligence (385)
ASCO (160)
Autoimmune disease (261)
Automation (34)
Bankruptcy (264)
Belgium (4)
Best Places to Work (6957)
BIO (36)
Biologics (63)
BIOSECURE Act (1)
Biosimilars (127)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (31)
Bladder cancer (150)
Brain cancer (37)
Breast cancer (554)
Cancer (4147)
Cardiovascular disease (249)
Career advice (245)
Career pathing (1)
CAR-T (196)
CDC (2)
CDMO (36)
Celiac Disease (3)
Cell therapy (537)
Cervical cancer (37)
Clinical research (48646)
Collaboration (1388)
Commercialization (35)
Compensation (1669)
Complete response letters (37)
COVID-19 (778)
CRISPR (75)
C-suite (873)
Cystic fibrosis (89)
Data (6758)
Denatured (4)
Depression (109)
Dermatology (106)
Diabetes (392)
Diagnostics (4287)
Digital health (43)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (178)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (176)
Earnings (74562)
Editorial (1)
Employer branding (2)
Employer resources (14)
ESMO (240)
Events (89276)
Executive appointments (745)
Eye disease (8)
FDA (12746)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (21)
Frontotemporal dementia (26)
Funding (1012)
Gene editing (140)
Generative AI (15)
Gene therapy (359)
GLP-1 (323)
Government (953)
Grass and pollen (2)
Guidances (288)
Healthcare (9450)
Hematology (115)
HIV (60)
Huntington's disease (30)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (82)
Immunology and inflammation (114)
Immuno-oncology (75)
Indications (190)
Infectious disease (988)
Inflammatory bowel disease (145)
Inflation Reduction Act (4)
Influenza (90)
Intellectual property (277)
Interviews (41)
IPO (12400)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (19)
Kidney disease (93)
Layoffs (59)
Legal (5195)
Licensing (69)
Liver cancer (47)
Longevity (28)
Lung cancer (589)
Lung diease (11)
Lymphoma (282)
Machine learning (30)
Management (3)
Manufacturing (631)
Marketing (25)
MASH (131)
Medical affairs (2)
Medical device (8730)
Medtech (8933)
Mergers & acquisitions (14496)
Metabolic disorders (801)
mRNA (82)
Multiple sclerosis (118)
Multispecific (3)
NASH (4)
Netherlands (4)
Neurodegenerative disease (250)
Neuropsychiatric disorders (41)
Neuroscience (1996)
Neurotech (2)
NextGen: Class of 2026 (3150)
Non-profit (845)
Obesity (250)
Opinion (10)
Ovarian cancer (185)
Pain (195)
Pancreatic cancer (240)
Parkinson's disease (220)
Partnered (12)
Patents (535)
Patient advocacy (3)
Patient recruitment (550)
Patient selection (55)
Peanut (34)
People (41578)
Peptides (25)
Pharmaceutical (30)
Pharmacy benefit managers (11)
Phase 1 (15707)
Phase 2 (21757)
Phase 3 (14676)
Pipeline (9124)
Policy (20)
Postmarket research (1570)
Preclinical (6624)
Press Release (34)
Prostate cancer (212)
Psychedelics (13)
Radiopharmaceuticals (205)
Rare diseases (642)
Real estate (3025)
Recruiting (6)
Regenerative medicine (18)
Regulatory (15266)
Reports (27)
Research institute (596)
Resumes & cover letters (45)
Rett syndrome (48)
RNA editing (9)
RSV (52)
Schizophrenia (112)
Series A (179)
Series B (129)
Service/supplier (5)
Sickle cell disease (70)
Spinal muscular atrophy (93)
Sponsored (5)
Startups (2021)
Stem cells (3)
Stomach cancer (3)
Substance use disorders (17)
Supply chain (57)
Switzerland (2)
Tariffs (2)
Vaccines (361)
Venture capital (18)
Weight loss (83)
Wet AMD (3)
Women's health (102)
Date
Today (147)
Last 7 days (627)
Last 30 days (2397)
Last 365 days (19275)
2026 (17428)
2025 (19252)
2024 (22988)
2023 (26538)
2022 (34586)
2021 (37167)
2020 (33468)
2019 (23257)
2018 (17468)
2017 (18764)
2016 (17917)
2015 (24264)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (233)
Alabama (81)
Alaska (2)
Arizona (332)
Arkansas (12)
Asia (18106)
Australia (2129)
California (13430)
Canada (3465)
China (596)
Colorado (552)
Connecticut (472)
Delaware (237)
Europe (24868)
Florida (1999)
Georgia (422)
Hawaii (3)
Idaho (46)
Illinois (803)
India (66)
Indiana (340)
Iowa (19)
Japan (469)
Kansas (106)
Kentucky (34)
Louisiana (30)
Maine (27)
Maryland (1320)
Massachusetts (8786)
Michigan (325)
Minnesota (623)
Mississippi (5)
Missouri (86)
Montana (20)
Nebraska (11)
Nevada (141)
New Hampshire (61)
New Jersey (2958)
New Mexico (12)
New York (3131)
North Carolina (1417)
North Dakota (4)
Northern California (6823)
Ohio (311)
Oklahoma (15)
Oregon (17)
Pennsylvania (2498)
Puerto Rico (24)
Rhode Island (32)
South America (407)
South Carolina (82)
South Dakota (1)
Southern California (5620)
Tennessee (133)
Texas (2222)
United States (43416)
Utah (405)
Vermont (1)
Virginia (169)
Washington D.C. (39)
Washington State (1022)
West Virginia (1)
Wisconsin (84)
Wyoming (1)
489,794 Results for "skinvisible inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Skinvisible Submits Innovative Obesity Patent for Advanced Transdermal Treatment
Skinvisible Pharmaceuticals, Inc., an innovative pharmaceutical research and development company, announced a major advancement in the battle against obesity.
May 29, 2024
·
4 min read
Skinvisible Expands Obesity Patent Application for Transdermal Delivery
Skinvisible Pharmaceuticals, Inc. (OTCQB:SKVI), an innovative topical / transdermal pharmaceutical research and development company, today announced the filing of a second patent application for its groundbreaking Invisicare® technology and its transdermal delivery of obesity and glucose-controlling agents.
June 24, 2024
·
5 min read
Skinvisible Announces Significant Progress in Licensee’s Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome
Skinvisible, Inc. (“Skinvisible”) (OTCQB:SKVI) is excited to share a promising update on the ongoing clinical trials conducted by its licensee, Quoin Pharmaceuticals, Inc. (“Quoin”) (NASDAQ:QNRX).
February 14, 2024
·
4 min read
Press Releases
Promising Data on Transdermal Obesity Formulations Announced by Skinvisible
July 12, 2024
·
4 min read
Policy
Skinvisible Announces First Invisicare Delivery Technology Product to Receive U.S. FDA Acceptance of Investigational New Drug
Skinvisible, Inc., is pleased to announce that its licensee Quoin Pharmaceuticals, Inc., has received U.S. FDA acceptance of its Investigational New Drug application for its licensed formulation which uses Skinvisible’s Invisicare® proprietary drug delivery technology.
June 6, 2022
·
3 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
Press Releases
Mint Pharmaceuticals Inc. and Bayer Inc. Expand Distribution Partnership in Canada
October 6, 2026
·
3 min read
Press Releases
Exicure, Inc. Announces Agreement to Sell GPC-100 Program Assets to GPCRT Inc. for KRW 6.5 Billion
November 10, 2026
·
4 min read
Press Releases
PharmaCyte Biotech, Inc. Announces Reverse Stock Split
November 11, 2026
·
3 min read
New Study Finds SkinVision Detects 95% of Skin Cancer
An international group of researchers working with Erasmus University Medical Center in the Netherlands determined that SkinVision – the first CE-marked skin cancer application based on extensive clinical trials – has a sensitivity of 95.1% in detecting the most common forms of skin cancer.
September 15, 2019
·
3 min read
1 of 48,980
Next